
LSB P/E Ratio
P/E Ratio as of Jun 16, 2025: 0.15
Average0.8586
Median0.1600
Minimum0.1400
Maximum1.72
0.15
Past Month-1.46 (90.68%)
The P/E ratio for LSB is 0.15 as of Jun 16, 2025. This represents a decrease of -93.70% compared to its 12-month average P/E ratio of 2.38. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
LakeShore Biopharma Co., Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
LakeShore Biopharma Co., Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing LakeShore Biopharma Co., Ltd to industry peers.
LakeShore Biopharma Co., Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
LakeShore Biopharma Co., Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing LakeShore Biopharma Co., Ltd to industry peers.
LSB P/E Ratio Insights
See LakeShore Biopharma Co., Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in LSB
Order type
Buy in
Order amount
Est. shares
0 shares
LSB P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $1.07 | 0.16 |
May 1, 2025 | $1.25 | 1.87 |
Apr 1, 2025 | $2.40 | 3.58 |
Mar 3, 2025 | $2.09 | 3.12 |
Feb 3, 2025 | $2.36 | 3.52 |
Jan 2, 2025 | $3.61 | 5.39 |
LSB End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | 0.15 | -97.09% |
2024 | 5.16 | +578.95% |
2023 | 0.76 | — |
FAQs About LakeShore Biopharma Co., Ltd (LSB) P/E ratio
The latest P/E ratio of LSB is 0.15, as of Jun 16, 2025. This is calculated based on its current stock price and earnings per share (EPS).
LakeShore Biopharma Co., Ltd’s last 12-month average P/E ratio is 2.38, compared to its current P/E ratio of 0.15. This reflects a decrease of -93.70%.
LakeShore Biopharma Co., Ltd’s current P/E ratio of 0.15 is lower than its last 12-month average P/E of 2.38. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
LakeShore Biopharma Co., Ltd’s average P/E ratio over the last 3 years is 1.82. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
LakeShore Biopharma Co., Ltd’s average P/E ratio over the last 5 years is 1.09. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.